Kenvue Inc.

KVUE

$19.31

-1.28%

Kenvue Inc.

Kenvue Inc. is a Consumer products company listed on NEW YORK STOCK EXCHANGE, INC..

Industry

Consumer products

Exchange

NEW YORK STOCK EXCHANGE, INC.

Market Cap

$37.1B

P/E Ratio

22.4

Cash on Hand

$1.1B(positive)

Shares Outstanding

1.92B shares

Currency

USD

Visit website →

About

Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual

Q3 2026$0.30$0.29

Q2 2026$0.33$0.31

Q1 2026$0.27$0.32

Q4 2025$0.23$0.27

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range

$14.02 – $20.13

The lowest and highest price this stock has traded at over the past year.

Dividend Yield

4.29%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin

10.8%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth

+1.8%

How much the company's sales grew compared to a year ago.

Volatility (Beta)

0.42

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Loading Company intelligence…

Analyst Insights

Analyst Consensus

Hold

Based on 20 analysts

Similar Companies

EL ELF IPAR BRBR COTY

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Howlett Heather

Oct 2, 2026 • $17.20/share

Bought 10,881

Howlett Heather

Oct 2, 2026 • $17.20/share

Sold 5,566

Tillett Caroline

Oct 2, 2026 • $17.20/share

Bought 24,732

Tillett Caroline

Oct 2, 2026 • $17.20/share

Sold 8,471

Stevens Meredith

Oct 2, 2026 • $17.20/share

Bought 35,754

Stevens Meredith

Oct 2, 2026 • $17.20/share

Sold 15,192

Latest SEC Filings

Loading filings…

← Back to homepage

Loading… fetching the latest figures.

Kenvue Inc.

KVUE

$19.31

-1.28%

Kenvue Inc.

Kenvue Inc. is a Consumer products company listed on NEW YORK STOCK EXCHANGE, INC..

Industry

Consumer products

Exchange

NEW YORK STOCK EXCHANGE, INC.

Market Cap

$37.1B

P/E Ratio

22.4

Cash on Hand

$1.1B(positive)

Shares Outstanding

1.92B shares

Currency

USD

Visit website →

About

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual

Q3 2026$0.30$0.29

Q2 2026$0.33$0.31

Q1 2026$0.27$0.32

Q4 2025$0.23$0.27

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range

$14.02 – $20.13

The lowest and highest price this stock has traded at over the past year.

Dividend Yield

4.29%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin

10.8%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth

+1.8%

How much the company's sales grew compared to a year ago.

Volatility (Beta)

0.42

Company Intelligence

Annual figures from the company's own SEC filings. Tap any number to open the filing it came from.

Revenue

Growth = this year ÷ prior year − 1

Dec 2025: $15.1B-2.1%
Dec 2024: $15.5B+0.1%
Dec 2023: $15.4B+3.3%
Jan 2023: $14.9B-0.7%

Operating income

Margin = operating income ÷ revenue

Dec 2025: $2.4B16.0% margin
Dec 2024: $1.8B11.9% margin
Dec 2023: $2.5B16.3% margin
Jan 2023: $2.7B17.9% margin

Net income

Margin = net income ÷ revenue

Dec 2025: $1.5B9.7% margin
Dec 2024: $1.0B6.7% margin
Dec 2023: $1.7B10.8% margin
Jan 2023: $2.1B13.8% margin

Operating cash flow

Cash the business generated, vs net income above

Dec 2025: $2.2B
Dec 2024: $1.8B
Dec 2023: $3.2B
Jan 2023: $2.5B

Cash vs long-term debt

Cash − long-term debt. Excludes short-term borrowings and leases

Dec 2025: —
Dec 2024: —
Dec 2023: -$6.3B$1.4B cash · $7.7B debt
Jan 2023: $1.2B$1.2B cash · $0 debt

Shares (weighted avg.)

Change = this year ÷ prior year − 1

Dec 2025: 1.92B+0.1%
Dec 2024: 1.92B+3.7%
Dec 2023: 1.85B+7.6%
Jan 2023: 1.72B-0.0%

Fiscal year ending	Dec 2025	Dec 2024	Dec 2023	Jan 2023
RevenueGrowth = this year ÷ prior year − 1	$15.1B-2.1%	$15.5B+0.1%	$15.4B+3.3%	$14.9B-0.7%
Operating incomeMargin = operating income ÷ revenue	$2.4B16.0% margin	$1.8B11.9% margin	$2.5B16.3% margin	$2.7B17.9% margin
Net incomeMargin = net income ÷ revenue	$1.5B9.7% margin	$1.0B6.7% margin	$1.7B10.8% margin	$2.1B13.8% margin
Operating cash flowCash the business generated, vs net income above	$2.2B	$1.8B	$3.2B	$2.5B
Cash vs long-term debtCash − long-term debt. Excludes short-term borrowings and leases	—	—	-$6.3B$1.4B cash · $7.7B debt	$1.2B$1.2B cash · $0 debt
Shares (weighted avg.)Change = this year ÷ prior year − 1	1.92B+0.1%	1.92B+3.7%	1.85B+7.6%	1.72B-0.0%

What the numbers show

Operating cash flow was at or above net income in all 4 profitable years shown.
Revenue fell in 2 of the last 4 fiscal years shown (Dec 2025, Jan 2023).
Operating margin was 17.9% in Jan 2023 and 16.0% in Dec 2025.
Weighted average shares increased 11.7% between Jan 2023 and Dec 2025.

Worth a closer look

Automatic checks on the figures above. A flag is a pattern to investigate, not a finding of wrongdoing, and each one lists ordinary explanations for it.

Share count rising

Weighted average shares rose 11.7% between Jan 2023 and Dec 2025 (0.1% in the latest year).

Shares (weighted avg.)	Dec 2025	1.92B
Shares (weighted avg.)	Dec 2024	1.92B
Shares (weighted avg.)	Jan 2023	1.72B

How it's calculated: Share growth = weighted average shares ÷ earlier-year weighted average shares − 1.

Rule: Weighted average shares up 5% or more in a year, or 10% or more over three years.

Why it matters, and ordinary explanations

Why it can matter: When a company issues new shares, each existing share becomes a smaller slice of the profits, so earnings per share can lag total earnings.

Common innocent explanations: Shares issued to pay for an acquisition or to fund growth, or employee share awards that vest over time.

See every flagged company in Market Watch →

Rules checked

Revenue up, operating cash flow down — not triggered. Revenue up 5% or more in the latest year while operating cash flow fell 10% or more.
Profit not matched by cash — not triggered. Net income positive, but operating cash flow below 70% of net income in each of the last two fiscal years.
Receivables growing faster than revenue — not run. Not enough comparable annual figures reported to run this check.
Share count rising — flagged. Weighted average shares up 5% or more in a year, or 10% or more over three years.
Operating margin shrinking — not triggered. Operating margin lower in each of the last two years, down 3 percentage points or more in total.

Source: SEC EDGAR annual reports (Form 10-K), latest filed 2026-02-20. If a company later restates a year, the most recent filing is used. Dashes mean the company did not report that line in a form we could read. For information only, not investment advice.

Loading Company intelligence…

Analyst Insights

Analyst Consensus

Hold

Based on 20 analysts

Similar Companies

EL ELF IPAR BRBR COTY

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Howlett Heather

Oct 2, 2026 • $17.20/share

Bought 10,881

Howlett Heather

Oct 2, 2026 • $17.20/share

Sold 5,566

Tillett Caroline

Oct 2, 2026 • $17.20/share

Bought 24,732

Tillett Caroline

Oct 2, 2026 • $17.20/share

Sold 8,471

Stevens Meredith

Oct 2, 2026 • $17.20/share

Bought 35,754

Stevens Meredith

Oct 2, 2026 • $17.20/share

Sold 15,192

Latest SEC Filings

Loading filings…

← Back to homepage